跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Zambon S.P.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 6, 2023
Approval ID
2d4a27f396f95023
Company
Zambon S.P.A.
Type
Standard
Approval Details
Approval Id
2d4a27f396f95023
Drug Cima Aemps Name
XADAGO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
114984003IP3
Holder Company Name
Zambon S.P.A.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2023-06-06
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Zambon S.P.A.
Active Ingredients
SAFINAMIDA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 6, 2023
Approval ID
2d4a27f396f95023
Type
Standard
Back to CIMA-AEMPS Approvals
